Joshua Hessler

Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes

Jason A. Dubovsky, Kyle A. Beckwith, Gayathri Natarajan et al. · Blood · 2013 · 796 citations

Life Sciences, Immunology, Pharmacology +14

Prophylactic versus Reactive PEG Tube Placement in Head and Neck Cancer

Scott Kramer, Matthew Newcomb, Joshua Hessler et al. · Otolaryngology · 2013 · 73 citations

Medicine, Oncology, Surgery +13

Up-regulation of CDK9 kinase activity and Mcl-1 stability contributes to the acquired resistance to cyclin-dependent kinase inhibitors in leukemia

Yuh-Ying Yeh, Rong Chen, Joshua Hessler et al. · Oncotarget · 2014 · 45 citations · Full text

Medicine, Cancer Biology, Oncology +17

Milatuzumab immunoliposomes induce cell death in CLL by promoting accumulation of CD74 on the surface of B cells

Erin Hertlein, Georgia Triantafillou, Ellen J. Sass et al. · Blood · 2010 · 43 citations · Full text

Life Sciences, Hematology, Immunology +8